MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSENBLATT, D. S.
Right arrow Articles by BEAULIEU, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSENBLATT, D. S.
Right arrow Articles by BEAULIEU, D.

Molecular Pharmacology, Vol 19, 87-91, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of Methotrexate Polyglutamate Accumulation in Cultured Human Cells

D. S. ROSENBLATT 1, V. M. WHITEHEAD 1, M.-J. VUCHICH 1, A. POTTIER 1, N. VERA MATIASZUK 1, and DENISE BEAULIEU 1

1 The McGill Centre for Human Genetics and the Medical Research Council Genetics Group, The Penny Cole Hematology Research Laboratory and the McGill Cancer Centre, McGill University-Montreal Children’s Hospital Research Institute, and Department of Pediatrics and Biology, McGill University, Montreal, Quebec, Canada

Incubation of confluent monolayers of human diploid fibroblasts in 1 µM [3H]methotrexate results in the accumulation of increasing levels of nonexchangeable intracellular methotrexate (MTX). This accumulation is due to metabolism of MTX to poly(ggr-glutamyl) derivatives of progressively longer polyglutamate chain length and retention of the latter in a nonexchangeable state. This metabolism is unaffected by the addition of 10 µM folic acid (pteroylglutamic acid) to the incubation medium. In contrast, the addition of 10 µM 5-formyltetrahydrofolate or 5-methyltetrahydrofolate results in cessation of synthesis of MTX polyglutamates and therefore cessation of accumulation of high intracellular total MTX levels. Direct evidence of depletion of the exchangeable intracellular pool of MTX derivatives suggests that the reduced folates act by competing with MTX for transport into cells. We cannot rule out that inhibition of polyglutamate accumulation may be due in part to competition of these reduced folates for the polyglutamate synthetase enzyme. Inhibition of polyglutamate synthesis by folinic acid and other reduced folates may play a role in the "rescue" of tissues from MTX toxicity.

Note:
ACKNOWLEDGMENTS We thank C. M. Baugh and M. G. Nair, Department of Biochemistry, University of South Alabama, for the kind provision of methotrexate polyglutamates. A.-M. Audet and Y. Guillemot were responsible for pilot studies from which this work derived. We thank Claire Pepin and Judy St. James for help in the preparation of the manuscript.

Submitted on September 17, 1979
Accepted on June 19, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics